SWHR commends Peter Rogers, Professor of Women’s Health Research, Department of Obstetrics and Gynecology, and Director of Research, Royal Women's Hospital at University of Melbourne for his commentary in Equal but not the same: a male bias reigns in medical research.
SWHR commends the outgoing Food and Drug Administration (FDA) Commissioner, Dr. Margaret Hamburg, for her profound service to improve American public health at the Agency.
President Barack Obama unveiled his budget request to Congress for the 2016 fiscal year, which provides for critical investment in research at our Nation’s premier science agencies.
Statement from Phyllis Greenberger, President and CEO of the Society for Women’s Health Research
The U.S. Food and Drug Administration (FDA) recently created Drug Trials Snapshots, a new website to give patients, providers, and caregivers information on the participation of people in clinical trials by sex, age, race, and ethnicity.
The Food and Drug Administration announced a final rule today that sets new standards for labeling information for prescription drugs and biological products.
SWHR congratulates the Food and Drug Administration’s (FDA) Office of Women’s Health for 20 years of working to improve the health of women.
SWHR would like to congratulate several leading members of the Organization for the Study of Sex Differences (OSSD) on the publication of their recent article "NIH initiative to balance sex of animals in preclinical studies: Generative questions to guide policy, implementation, and metrics."
The National Institutes of Health (NIH) announced that it will invest $10.1 million in supplemental funding to support the research of more than 80 grantees to investigate the effects of sex in pre-clinical and clinical studies.